Henrik Zetterberg

6 ta ish

University College London

1. Biomarkers for Alzheimer's disease: current status and prospects for the future

   Kaj Blennow, Henrik Zetterberg

   Sharh maqolaOAOchiq kirish20183 iqtibos

   ABIABI:AkademIndex/2026.other.247102

2. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

   Kaj Blennow, Harald Hampel, Michael W. Weiner +1

   Sharh maqola20103 iqtibos

   ABIABI:AkademIndex/2026.other.292441

3. Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

   Piotr Lewczuk, Peter Riederer, Sid E. O’Bryant +55

   Sharh maqola20173 iqtibos

   ABIABI:AkademIndex/2026.other.480895

4. <scp>CSF</scp> A<i>β</i>42/A<i>β</i>40 and A<i>β</i>42/A<i>β</i>38 ratios: better diagnostic markers of Alzheimer disease

   Shorena Janelidze, Henrik Zetterberg, Niklas Mattsson +9

   Maqola20162 iqtibos

   ABIABI:AkademIndex/2026.other.775815

5. USING FLORBETAPIR PET TO INCREASE DIAGNOSTIC CERTAINTY IN ATYPICAL DEMENTIAS

   PSJ Weston, RW Paterson, M Lehmann +13

   MaqolaAlzheimer's disease research and treatmentsJournal of Neurology Neurosurgery & Psychiatry20150 iqtibos

   ABIABI:AkademIndex/2015.article.000645

6. The 2022 symposium on dementia and brain aging in low‐ and middle‐income countries: Highlights on research, diagnosis, care, and impact

   Raj N. Kalaria, Gladys E. Maestre, Simin Mahinrad +79

   Sharh maqolaOAOchiq kirishDementia and Cognitive Impairment ResearchAlzheimer s & Dementia20240 iqtibos

   ABIABI:AkademIndex/2024.review-article.000002